Search results
Hims & Hers is selling an Ozempic knockoff without FDA approval. Here's how
Quartz· 10 hours agoThe millennial-skewed telehealth platform Hims & Hers this week joined several online pharmacies in...
FDA grants approval for two Eylea biosimilars for eye conditions
Pharmaceutical Technology via Yahoo Finance· 20 hours agoBiocon Biologics CEO and managing director Shreehas Tambe stated: “The FDA approval of Yesafili...
What's Going On With Colorectal Cancer Diagnostic-Focused Guardant Health Stock On Tuesday?
Benzinga via Yahoo Finance· 8 hours agoTuesday, the FDA's staff reviewers raised concerns regarding Guardant Health Inc's (NASDAQ:GH)...
It’s Official: Tara Flour Is an Unapproved Food Additive, According to the FDA
Eating Well via Yahoo News· 8 hours agoTara flour made headlines in 2022 after hundreds got sick from Daily Harvest crumbles. Now the FDA...
Louisiana House Votes To Jail People For Possessing Abortion Pills
HuffPost via Yahoo News· 3 hours agoIn 2023, the Guttmacher Institute found the medications accounted for 63% of all abortions in the...
FDA Roundup: May 21, 2024
FOX 4 Kansas City· 8 hours agoAdditional information about these medications, including their risks and side effects, can be found at the CDER notable approval webpage. On Monday, the FDA</ ...
US FDA staff says Guardant's test may fail to detect some pre-cancerous tumors
Reuters via Yahoo News· 15 hours agoThe reviewers, however, said the test may increase compliance with screening for colorectal cancer...
Q1 2024 Biomx Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 7 minutes ago...re using forward-looking statements when we discuss in the conference call, the sufficiency of the combined company's financing potential stockholder approval of certain matters related to the securities issued and related matters in connection with the Adaptive Phage ...recruitment, aim expected...
FDA Grants Withdrawal of Infigratinib for Cholangiocarcinoma
Medscape· 23 hours agoThe US Food and Drug Administration (FDA) has announced the withdrawal of its 2021 accelerated approval of infigratinib (Truseltiq) for patients with a ...
FDA sets new review date for Halozyme's drug delivery tech By Investing.com
Investing.com· 11 hours agoHalozyme (NASDAQ:HALO) Therapeutics, Inc. (NASDAQ: HALO) announced that the U.S. Food and Drug...
